Drug Shortage Report for JAMP-FLUOXETINE

Last updated on 2025-03-03 History
Report ID 218706
Drug Identification Number 02401894
Brand name JAMP-FLUOXETINE
Common or Proper name Fluoxetine Capsules BP (as fluoxetine hydrochloride)
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) FLUOXETINE
Strength(s) 10MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-05
Estimated end date 2025-06-30
Actual end date
Shortage status Actual shortage
Updated date 2025-03-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2025-03-03 French Compare
v12 2025-03-03 English Compare
v11 2025-01-23 French Compare
v10 2025-01-23 English Compare
v9 2024-11-01 French Compare
v8 2024-11-01 English Compare
v7 2024-07-03 French Compare
v6 2024-07-03 English Compare
v5 2024-07-03 English Compare
v4 2024-03-19 French Compare
v3 2024-03-19 English Compare
v2 2024-02-07 French Compare
v1 2024-02-07 English Compare

Showing 1 to 13 of 13